0.8778
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.8465
Aprire:
$0.85
Volume 24 ore:
2,470
Relative Volume:
0.07
Capitalizzazione di mercato:
$48.00M
Reddito:
$117.93M
Utile/perdita netta:
$5.00M
Rapporto P/E:
6.6804
EPS:
0.1314
Flusso di cassa netto:
$-12.91M
1 W Prestazione:
+7.05%
1M Prestazione:
+8.37%
6M Prestazione:
-33.04%
1 anno Prestazione:
-43.29%
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
INCR
Intercure Ltd
|
0.8778 | 46.29M | 117.93M | 5.00M | -12.91M | 0.1314 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-05-18 | Aggiornamento | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Borsa (INCR) Ultime notizie
INCR Q2 2023 Earnings: EPS Surges Past Estimates as Company Delivers Strong Operational ResultsEarnings Trend Analysis - Newser
INCR Q2 2023 Earnings: EPS Surprises 28.68% Above Estimates Despite Negative Stock ReactionSocial Signal Watchlist - Newser
INCR (Intercure) beats Q2 estimates by 28% but shares fall 4% despite earnings surprise.AI Stock Signals - newser.com
How Intercure (INCR) performance reflects its true potential (Smart Money Flows) 2026-05-05Real Trader Insights - newser.com
InterCure Posts 2025 Revenue Growth, Positive Cash Flow as Recovery and Expansion Accelerate - The Globe and Mail
InterCure (NASDAQ: INCR) grows 2025 revenue to NIS 270M with positive cash flow - Stock Titan
InterCure Ltd. Reports NIS 270 Million Revenue and Positive Cash Flow for 2025 Amid Recovery Efforts - Quiver Quantitative
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow - Weekly Voice
Intercure LTD (INCR) Releases Q4 2025 Earnings: Revenue Up 43.8% but Company Remains Unprofitable - Quiver Quantitative
InterCure (INCR) 2025 20-F outlines licensing, war and market risks - Stock Titan
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Intercure (INCR) director discloses shares and stock options - Stock Titan
Intercure (INCR) director reports 15,000 share options at $3.10 strike - Stock Titan
Intercure (INCR) CEO details major share, warrant and option holdings - Stock Titan
David Salton Net Worth (2026) - GuruFocus
Amos Cohen Net Worth (2026) - GuruFocus
Gideon Hirschfeld Net Worth (2026) - GuruFocus
Intercure (INCR) CFO discloses option grants and share stake - Stock Titan
Intercure (INCR) director Gideon Hirschfeld reports existing stock option grants - Stock Titan
Intercure (INCR) director David Salton reports option positions in Form 3 - Stock Titan
Intercure (INCR) Stock: Portfolio Addition? (Selling Pressure) 2026-04-15Hull Moving Average - Newser
Investment Report: Whats the fair value of InterCure Ltd stockRisk Management & Consistent Growth Stock Picks - baoquankhu1.vn
Aug Levels: Is InterCure Ltd being accumulated by smart moneyExit Point & Weekly Breakout Stock Alerts - baoquankhu1.vn
Analyst Calls: How volatile is InterCure Ltd stock2026 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
INCR PE Ratio & Valuation, Is INCR Overvalued - Intellectia AI
INCR Price Today: Intercure Ltd. Stock Price, Quote & Chart - MEXC Exchange
Stock Report: Is InterCure Ltd a potential multi bagger2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
Aug Update: Should I invest in InterCure Ltd before earnings2026 Top Decliners & Fast Moving Trade Plans - baoquankhu1.vn
INCR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Highs Report: Why is InterCure Ltd stock going up2026 Performance Recap & Weekly Setup with High ROI Potential - baoquankhu1.vn
Stock Analysis: Is InterCure Ltd being accumulated by smart money2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
Aug Highlights: What are analysts price targets for InterCure LtdTreasury Yields & Accurate Intraday Trade Tips - baoquankhu1.vn
Intercure (INCR) Stock Analysis Report | Financials & Insights - Benzinga Japan
Market Fear: Is HCAT stock forming a triangle patternProduct Launch & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Will InterCure Ltd. stock split again soon2025 Analyst Calls & Daily Entry Point Trade Alerts - Naître et grandir
Aug Analyst Calls: Is InterCure Ltd a potential multi baggerWeekly Trade Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
INCR Earnings History & Surprises | EPS & Revenue Results | INTERCURE LTD (NASDAQ:INCR) - chartmill.com
INCR,UMBF Revenue Breakdown - Finviz
InterCure Faces Nasdaq Compliance Deadline After Bid-Price Breach - The Globe and Mail
InterCure receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Canada
InterCure receives Nasdaq notice for minimum bid price deficiency - Investing.com South Africa
InterCure Receives Noncompliance Notice From Nasdaq - marketscreener.com
InterCure receives Nasdaq notification regarding minimum bid requirement - marketscreener.com
Nasdaq warns InterCure (Nasdaq: INCR) on sub-$1 share price and listing - Stock Titan
InterCure Ltd. Receives Nasdaq Compliance Notice Due to Bid Price Deficiency, Plans to Regain Compliance - Quiver Quantitative
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewswire
InterCure weighs reverse share split after Nasdaq warns on sub-$1 stock price - Stock Titan
INCR Technical Analysis & Stock Price Forecast - Intellectia AI
Earnings Recap: Will RDACU outperform its industry peersJuly 2025 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
What’s the fair value of InterCure Ltd. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans - The Globe and Mail
Intercure Ltd Azioni (INCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):